Manejo de la hiperglucemia en el código sepsis (HYSE-Code)
- Matías Soler, Pablo 1
- Gil Mosquera, Marina 1
- Mostaza Gallar, Paula 2
- Perales Muñoz, Raúl 1
- González del Castillo, Juan María 1
- Fuentes Ferrer, Manuel 3
- 1 Servicio de Urgencias. Hospital Clínico San Carlos. Madrid, España.
- 2 Servicio de Urgencias. Hospital de Getafe. Madrid, España.
- 3 Servicio de Medicina Preventiva. Hospital Clínico San Carlos. Madrid, España.
ISSN: 2951-6552, 2951-6544
Année de publication: 2022
Volumen: 1
Número: 2
Pages: 93-96
Type: Article
D'autres publications dans: Revista Española de Urgencias y Emergencias
Résumé
BACKGROUND. The sepsis code is a tool for the early detection and treatment of patients with sepsis. Hyperglycemia is a known risk factor for poor in-hospital prognosis in the management of sepsis. We do not currently know if hyperglycemia is being treated in patients assessed under the code and if treatment has an impact on prognosis. MATERIALS AND METHODS. Retrospective observational study of all patients over the age of 18 years treated under the sepsis code in an emergency department from May to September 2018. RESULTS. Data for 128 patients were included. Most infections involved the respiratory tract (55%). Hyperglycemia was present in 37.5%, and 19% of them received treatment for it. Although mortality tended to be lower in patients whose hyperglycemia was treated, the difference was not statistically significant. CONCLUSIONS. Hyperglycemia is not being treated in sepsis-code cases. Further studies are needed to understand the prognostic implications.